Generate a tailored SOP for Dr. Adeline Vanderver. Improve your application with a focused, well-structured draft.
Dr. Adeline Vanderver is an attending physician and the program director of the Leukodystrophy Center at Children's Hospital Philadelphia. She holds the Jacob Kamens Endowed Chair for Neurologic Disorders and is highly specialized in leukodystrophies, which are inherited degenerative diseases affecting white matter in the brain and spinal cord. Throughout her career, Dr. Vanderver has dedicated herself to identifying genetic causes of leukodystrophies using advanced next-generation sequencing techniques. Her leadership at the Leukodystrophy Center has focused on creating new standards for the care of children with these disorders, advancing gene discoveries, and developing new therapies while advocating for patients and families. In addition to her clinical work, Dr. Vanderver is leading multiple clinical studies, including trials to repurpose existing medications for treating patients with Aicardi-Goutieres syndrome. Her research interests also include molecular therapeutics targeting specific genetic subtypes of leukodystrophies. Dr. Vanderver's efforts to promote awareness through the Global Leukodystrophy Initiative underscore her commitment to ensuring that affected families receive adequate medical and social support.
Childrens Hospital Philadelphia • Philadelphia, PA
Leading physician specializing in neurologic disorders, with a focus on leukodystrophies and genetic research.
Department of Pediatrics: Pediatric Residency Program. Interviews are conducted virtually.